Clinical Trials Directory

Trials / Sponsors / Han Xu, M.D., Ph.D., FAPCR, Sponsor-Investigator, IRB Chair

Han Xu, M.D., Ph.D., FAPCR, Sponsor-Investigator, IRB Chair

Industry · 10 registered clinical trials.

StatusTrialPhaseStarted
Active Not RecruitingPharmacogenomics IND EXEMPT SNP Clinical Trial - Alectinib and Single Nucleotide Polymorphisms
Non-small Cell Lung Cancer
Phase 2 / Phase 32026-03-18
Active Not RecruitingProof-of-Concept Clinical Pharmacology Trial for HIV Antigen Presentation Therapeutic Biologic Mix
HIV Infections
EARLY_Phase 12025-09-12
Active Not RecruitingPharmacogenomics ANDA SNP Clinical Study - Topotecan and Single Nucleotide Polymorphisms
SCLC
Phase 2 / Phase 32025-08-12
Active Not RecruitingPharmacogenomics ANDA SNP Clinical Study - Etoposide and Single Nucleotide Polymorphisms
Small Cell Lung Cancer
Phase 2 / Phase 32025-07-16
Active Not RecruitingBioequivalence ANDA SNP Clinical Study - Raloxifene and Single Nucleotide Polymorphisms
Breast Cancer
Phase 2 / Phase 32025-06-21
Active Not RecruitingGeneric Drugs (Dapagliflozin and Saxagliptin) Treat Type 2 Diabetes Patients With Controlled Cancers
Type 2 Diabetes
Phase 2 / Phase 32025-06-15
Active Not RecruitingProof-of-Concept Clinical Pharmacology Trial for COVID-19 Antigen Presentation Therapeutic Biologic Mix
Covid19
EARLY_Phase 12025-05-18
Active Not RecruitingEarly Phase Clinical Trial About Therapeutic Biological Product Mix for Treating HPV
HPV Infection
EARLY_Phase 12025-04-28
Active Not RecruitingPharmacogenomics IND Commercial SNP Clinical Study - Abiraterone and Single Nucleotide Polymorphisms
Prostate Cancer
Phase 2 / Phase 32023-08-18
Active Not RecruitingEarly Phase Clinical Trial About Therapeutic Biological Product Mix for Treating CEA Positive Rectal Cancer
Rectal Cancer
Phase 12021-12-28